ArticleJournal of medical case reports2025
Acute infectious purpura fulminant due to Enterococcus faecium infection: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPurpura fulminant is a rare life-threatening disorder characterized by a dysregulated response that is often associated with poor prognosis and lethal outcomes. It is often associated with disseminated intravascular coagulation, skin necrosis, and protein C deficiency leading to thrombotic occlusion of skin arterioles, causing palpable purpuric lesions, spreading ecchymosis, and gangrene, along with hypotension and fever. Purpura fulminant is classified into three distinct categories according to the trigger mechanisms, including neonatal, idiopathic, and acute infectious. Acute infectious purpura fulminant is the most common manifestation, which occurs after bacterial infections caused by acquired protein C deficiency. Although traditionally occurring in Neisseria meningitidis infection and Streptococcus infection, acquired protein C deficiency causing purpura fulminant due to Enterococcus faecium has not been described in the literature. This case report highlights the fact that purpura fulminans can also be a rare presentation of Entercoccus faecium infection. CASE PRESENTATION: A 61-year-old Arab man who is immunocompetent presented with sepsis, which later escalated into septic shock due to Enterococcus faecium bacteremia. The patient's hospitalization rapidly developed into multiorgan dysfunction, disseminated intravascular coagulation, and purpura fulminans. Aggressive interventions were initiated, involving the administration of broad-spectrum antibiotics, multiple vasopressors, and mechanical ventilation. Despite these intensive measures, the patient ultimately succumbed to the complications of multiorgan failure and death.
conclusionThis case illustrates the devastating outcomes that can present from purpura fulminant. However, physicians should consider purpura fulminant caused by Enterococcus faecium infection in the workup of patients presenting with purpuric rash and fever.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.